| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |